http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114822722-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F16-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F16-2433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B35-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F16-242
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16C20-64
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16C20-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F16-242
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F16-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B35-20
filingDate 2022-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114822722-B
titleOfInvention A screening method for effective substances of traditional Chinese medicine for treating hepatitis
abstract The invention discloses a method for screening effective substances of traditional Chinese medicine for treating hepatitis. Based on correlation map and molecular fingerprint similarity technology, a method capable of verifying the possible pharmacodynamic mechanism and material basis of Chinese medicine for treating hepatitis is proposed and the corresponding one is screened out. The key active ingredient; for the hepatitis differential gene, based on the association map technology, the candidate small molecule drug with the potential to treat the hepatitis was screened from the CMAP database; a set of omics and clinical big data for different hepatitis patients was formed , using target-based similarity reasoning and molecular fingerprint similarity analysis methods to screen small molecular compounds and verify the effectiveness of their associated drugs, so as to solve the research on the pharmacodynamic substances of anti-hepatitis traditional Chinese medicine with the potential to treat different hepatitis patients The questions provide technical support and methodological guidance, and also provide more effective traditional Chinese medicine treatment options for clinical hepatitis treatment.
priorityDate 2022-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425561568
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3083811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24794418
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419592563
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5330286
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423356136
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425966085
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426072367
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51402809
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5318645

Total number of triples: 31.